Table 1 Demographic data and blood eosinophil counts of patients with GC-sensitive NP and GC-insensitive NP
Objective sensitivity | Subjective sensitivity | |||||
|---|---|---|---|---|---|---|
GC-sensitive (n = 25) | GC-insensitive (n = 22) | P value | GC-sensitive (n = 29) | GC-insensitive (n = 18) | P value | |
Male, NO. (%) | 16 (64) | 12 (54.5) | .56 | 18 (62) | 10 (55.6) | .76 |
Age, mean (SD) (years) | 39.5 (12.7) | 34.8 (11.9) | .21 | 40.4 (11.7) | 32.4 (12.3) | .03 |
Disease duration (years) | 6.4 (8.4) | 8.5 (9.0) | .4 | 7.8 (10.1) | 6.8 (6.0) | .7 |
Smoking, NO. (%) | 3 (12) | 3 (13.6) | > .99 | 5 (17.2) | 1 (5.6) | .38 |
Eosinophil count, mean (SD) (cells/μL) | 404.4 (200.3) | 209.5 (233.1) | .003 | 401.4 (213.6) | 171.1 (200.2) | < .001 |
Eosinophil ratio, mean (SD) | 5.25 (2.59) | 3.17 (3.46) | .02 | 5.39 (2.76) | 2.48 (2.99) | < .001 |
NPSS before treatment, mean (SD) | 5.72 (1.37) | 5.64 (1.29) | .83 | 5.76 (1.38) | 5.56 (1.25) | .61 |
NPSS after treatment, mean (SD) | 4.28 (1.46) | 5.77 (1.31) | < .001 | 4.55 (1.62) | 5.67 (1.24) | .02 |
TNSS before treatment, mean (SD) | 8.8 (2.25) | 8.05 (1.86) | .22 | 9.07 (1.71) | 7.44 (2.31) | .01 |
TNSS after treatment, mean (SD) | 6.5 (1.71) | 7.59 (1.79) | .04 | 6.53 (1.68) | 7.78 (1.8) | .02 |
Atopy, NO. (%) | 17 (68) | 13 (59.1) | .45 | 21 (72.4) | 9 (50) | .16 |
Asthma, NO. (%) | 11 (44) | 3 (13.6) | .02 | 12 (41.4) | 2 (11.1) | .03 |
AR, NO. (%) | 11 (44) | 7 (31.8) | .4 | 14 (48.3) | 4 (22.2) | .12 |
AERD, NO. (%) | 1 (4) | 1 (4.5) | .93 | 1 (3.4) | 1 (5.6) | .73 |